Studies with the ApcMin/+ transgenic mouse model for CRC development showed that cyclin D2 is upregulated immediately after Apc loss in cells with deregulated Wnt/β-catenin signaling and that cyclin D2 deficiency reduces the proliferation and tumor burden after Apc loss [49,51]. This evidence concerns the gene APC and neoplasm.